“Benefits of Rosuvastatin in Cardiovascular Protection Remain Unclear After HOPE-3 ”. The Review of Diabetic Studies 13, no. 4 (August 21, 2016). Accessed February 1, 2026. https://diabeticstudies.org/index.php/RDS/article/view/93.